Skip to main content
Figure 6 | Molecular Cancer

Figure 6

From: RETRACTED ARTICLE: α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway

Figure 6

α-santalol inhibited the activation of AKT/mTOR/p70S6K pathway. (A) PC-3 cells (B) LNCaP cells (C) α-santalol inhibits tumor angiogenesis in vivo by suppressing activation of AKT/mTOR/p70S6K pathway in PC-3 xenograft tumor model. Values are mean ± SEM (n = 6) of three independent experiments. (D) Schematic diagram of the mechanism by which α-santalol inhibited tumor growth and angiogenesis in HUVECs and prostate tumor growth.

Back to article page

Molecular Cancer

ISSN: 1476-4598